To evaluate the role of percutaneous Tru-Cut needle liver biopsy in undiagnosed cases of hepatomegaly, a one & half year study was carried out at the department of Pediatrics, PGMI/LRH, Peshawar. A total of 50 liver biopsies were done. All those patients were subjected to liver biopsy that were having clinical hepatomegaly and remained undiagnosed with the routine non-invasive investigations done in our hospital. Out of the total 50 cases, cirrhosis was found in 14(28%), cases chronic active hepatitis 13(26%) of cases, storage disorders 10(20%) of cases and fatty change 3(6%) of cases. Liver biopsy results were inconclusive in 5(10%) of the cases. None of the patients showed any evidence of side effects after the procedure. Thus the study showed that liver biopsy is a safe procedure even with Tru-Cut needle in children and provides diagnostically important information.